Sort by

Send to

Choose Destination

Links from PubMed

Items: 17


Metastasis-associated lung adenocarcinoma transcript 1 promotes the proliferation of chondrosarcoma cell via activating Notch-1 signaling pathway.

Xu F, Zhang ZQ, Fang YC, Li XL, Sun Y, Xiong CZ, Yan LQ, Wang Q.

Onco Targets Ther. 2016 Apr 13;9:2143-51. doi: 10.2147/OTT.S100003. eCollection 2016.


Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma.

Fu H, Ma C, Guan W, Cheng W, Feng F, Wang H.

Onco Targets Ther. 2016 Mar 15;9:1519-23. doi: 10.2147/OTT.S98239. eCollection 2016.


3D Chromosome Regulatory Landscape of Human Pluripotent Cells.

Ji X, Dadon DB, Powell BE, Fan ZP, Borges-Rivera D, Shachar S, Weintraub AS, Hnisz D, Pegoraro G, Lee TI, Misteli T, Jaenisch R, Young RA.

Cell Stem Cell. 2016 Feb 4;18(2):262-75. doi: 10.1016/j.stem.2015.11.007. Epub 2015 Dec 10.


Theaflavin-3, 3'-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways.

Gao Y, Rankin GO, Tu Y, Chen YC.

Int J Oncol. 2016 Jan;48(1):281-92. doi: 10.3892/ijo.2015.3257. Epub 2015 Nov 20.


A 10-gene expression signature of Notch pathway predicts recurrence in ovarian carcinoma.

Chen F, Liu N.

Oncol Lett. 2015 Sep;10(3):1704-1708. Epub 2015 Jun 16.


Notch signaling in prostate cancer: refining a therapeutic opportunity.

Su Q, Xin L.

Histol Histopathol. 2016 Feb;31(2):149-57. doi: 10.14670/HH-11-685. Epub 2015 Nov 2. Review.


Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.

Verbeke LP, Van den Eynden J, Fierro AC, Demeester P, Fostier J, Marchal K.

PLoS One. 2015 Jul 28;10(7):e0133503. doi: 10.1371/journal.pone.0133503. eCollection 2015.


Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer.

Baker AT, Zlobin A, Osipo C.

Front Oncol. 2014 Dec 12;4:360. doi: 10.3389/fonc.2014.00360. eCollection 2014. Review.


Notch signaling in serous ovarian cancer.

Groeneweg JW, Foster R, Growdon WB, Verheijen RH, Rueda BR.

J Ovarian Res. 2014 Nov 4;7:95. doi: 10.1186/s13048-014-0095-1. Review.


Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growth.

Groeneweg JW, DiGloria CM, Yuan J, Richardson WS, Growdon WB, Sathyanarayanan S, Foster R, Rueda BR.

Front Oncol. 2014 Jul 7;4:171. doi: 10.3389/fonc.2014.00171. eCollection 2014.


NOTCH2 expression is decreased in epithelial ovarian cancer and is related to the tumor histological subtype.

Galic V, Shawber CJ, Reeves C, Shah M, Murtomaki A, Wright J, Herzog T, Tong GX, Kitajewski J.

Pathol Discov. 2013 Aug 16;1:4.


Gamma secretase inhibitors of Notch signaling.

Olsauskas-Kuprys R, Zlobin A, Osipo C.

Onco Targets Ther. 2013 Jul 23;6:943-55. doi: 10.2147/OTT.S33766. Print 2013.


The role of Notch and gamma-secretase inhibition in an ovarian cancer model.

Shah MM, Zerlin M, Li BY, Herzog TJ, Kitajewski JK, Wright JD.

Anticancer Res. 2013 Mar;33(3):801-8.


Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A.

Zhang X, Samadi AK, Roby KF, Timmermann B, Cohen MS.

Gynecol Oncol. 2012 Mar;124(3):606-12. doi: 10.1016/j.ygyno.2011.11.044. Epub 2011 Dec 3.


Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.

McGowan PM, Simedrea C, Ribot EJ, Foster PJ, Palmieri D, Steeg PS, Allan AL, Chambers AF.

Mol Cancer Res. 2011 Jul;9(7):834-44. doi: 10.1158/1541-7786.MCR-10-0457. Epub 2011 Jun 10.


Therapeutic advances in women's cancers.

Carroll AR, Coleman RL, Sood AK.

Front Biosci (Schol Ed). 2011 Jan 1;3:82-97. Review.

Items per page

Supplemental Content

Write to the Help Desk